{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T02:54:38Z","timestamp":1649127278968},"reference-count":65,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice & Research Clinical Obstetrics & Gynaecology"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1016\/j.bpobgyn.2008.11.003","type":"journal-article","created":{"date-parts":[[2009,1,15]],"date-time":"2009-01-15T09:15:20Z","timestamp":1232010920000},"page":"211-220","source":"Crossref","is-referenced-by-count":2,"title":["Contraception and gynaecological care"],"prefix":"10.1016","volume":"23","author":[{"given":"Sharon","family":"Cameron","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpobgyn.2008.11.003_bib2","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1136\/bmj.39289.649410.55","article-title":"Cancer risk among users of ral contraceptives: cohort data from the Royal College of General Practitioners oral contraception study","volume":"335","author":"Hannaford","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/j.bpobgyn.2008.11.003_bib3","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0140-6736(08)60167-1","article-title":"Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23\u2008257 women with ovarian cancer and 87\u2008303 controls","volume":"371","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.bpobgyn.2008.11.003_bib4","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1023\/A:1008945721786","article-title":"Use of oral contraceptives and endometrial cancer risk (Sweden)","volume":"10","author":"Wiederpass","year":"1999","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.bpobgyn.2008.11.003_bib5","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/sj.bjc.6603260","article-title":"Oral contraceptive use and cancer: findings in a large cohort 1968\u20132004","volume":"95","author":"Vessey","year":"2006","journal-title":"Br J Cancer"},{"key":"10.1016\/j.bpobgyn.2008.11.003_bib6","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1067\/mob.2003.346","article-title":"Treatment of non atypical, endometrial hyperplasia with a levonorgestrel intrauterine system","volume":"188","author":"Wildermeersch","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2008.11.003_bib7","first-page":"642","article-title":"Levonorgestrel IUS \u2013 treatment for endometrial cystic hyperplasia","volume":"2","author":"Rose","year":"2001","journal-title":"J Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2008.11.003_bib8","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.jmig.2008.08.016","article-title":"Endometrioid adenocarcinoma after insertion of a levonorgestrel-releasing intrauterine system","volume":"15","author":"Flemming","year":"2008","journal-title":"J Minim Invasive Gynecol"},{"key":"10.1016\/j.bpobgyn.2008.11.003_bib9","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/hmg\/6.1.105","article-title":"Cancer risk associated with germline DNA mismatch repair gene mutations","volume":"6","author":"Dunlop","year":"1997","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.bpobgyn.2008.11.003_bib10","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/00006254-200202000-00024","article-title":"Noncontraceptive health benefits of intrauterine devices: a systematic review","volume":"57","author":"Hubacher","year":"2002","journal-title":"Obstet Gynecol Surv"},{"key":"10.1016\/j.bpobgyn.2008.11.003_bib11","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1111\/j.1471-0528.2007.01545.x","article-title":"A randomised controlled trial of prophylactic levonorgestrel intrauterine system in tamoxifen-treated women","volume":"114","author":"Chan","year":"2007","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.bpobgyn.2008.11.003_bib12","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/S0140-6736(00)03204-9","article-title":"Endometrial protection from tamoxifen-stimulated changes by a levonorgestrel-releasing intrauterine system: a randomised controlled trial","volume":"356","author":"Gardner","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.bpobgyn.2008.11.003_bib13","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.fertnstert.2007.05.033","article-title":"Use of the levonorgestrel-releasing intrauterine system in breast cancer patients","volume":"90","author":"Trinh","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2008.11.003_bib14","author":"World Health Organization"},{"key":"10.1016\/j.bpobgyn.2008.11.003_bib16","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1136\/bmj.294.6586.1518","article-title":"Ovarian neoplasms, functional ovarian cysts, and oral contraceptives","volume":"294","author":"Vessey","year":"1987","journal-title":"BMJ"},{"key":"10.1016\/j.bpobgyn.2008.11.003_bib17","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1136\/jech.46.5.528","article-title":"A case-control study of benign ovarian tumours","volume":"46","author":"Booth","year":"1992","journal-title":"J Epidemiol Commun Health"},{"key":"10.1016\/j.bpobgyn.2008.11.003_bib18","first-page":"529","article-title":"Functional ovarian cysts in relation to the use of monophasic and triphasic oral contraceptives","volume":"79","author":"Holt","year":"1992","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2008.11.003_bib19","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/0002-9378(92)91371-G","article-title":"Oral contraceptive type and functional ovarian cysts","volume":"166","author":"Lanes","year":"1992","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2008.11.003_bib20","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3109\/09513599509160463","article-title":"The influence of the dose of ethinylestradiol in oral contraceptives on follicle growth","volume":"9","author":"Teichmann","year":"1995","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.bpobgyn.2008.11.003_bib21","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S0015-0282(16)53930-2","article-title":"Hormonal treatment of functional ovarian cysts: a randomized, prospective study","volume":"54","author":"Steinkampf","year":"1990","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2008.11.003_bib22","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0020-7292(94)90570-3","article-title":"Expectant management of functional ovarian cysts: an alternative to hormonal therapy","volume":"47","author":"Turan","year":"1994","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.bpobgyn.2008.11.003_bib23","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0306-5456(00)00020-6","article-title":"The effectiveness of the levonorgestrel-releasing intrauterine system in menorrhagia: a systematic review","volume":"108","author":"Stewart","year":"2001","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.bpobgyn.2008.11.003_bib24","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1136\/bmj.38376.505382.AE","article-title":"Trends in number of hysterectomies performed in England for menorrhagia: examination of health episode statistics, 1989 to 2002\u20133","volume":"330","author":"Reid","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.bpobgyn.2008.11.003_bib25","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002126.pub2","article-title":"Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding","volume":"19","author":"Lethaby","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.bpobgyn.2008.11.003_bib26","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1001\/jama.291.12.1456","article-title":"Clinical outcomes and costs with levonorgestrel-releasing intrauterine system or hysterectomy for treatment of menorrhagia: randomized trial 5-year follow-up","volume":"291","author":"Hurskainen","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.bpobgyn.2008.11.003_bib27","author":"National Institute for Health and Clinical Excellence"},{"key":"10.1016\/j.bpobgyn.2008.11.003_bib28","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0010-7824(92)90095-B","article-title":"The influence of a low-dose combined oral contraceptive on menstrual blood loss and iron status","volume":"46","author":"Larsson","year":"1992","journal-title":"Contraception"},{"key":"10.1016\/j.bpobgyn.2008.11.003_bib29","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1479-828X.1991.tb02769.x","article-title":"Randomized trial of 2 hormonal and 2 prostaglandin-inhibiting agents in women with a complaint of menorrhagia","volume":"31","author":"Fraser","year":"1991","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/j.bpobgyn.2008.11.003_bib30","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.contraception.2006.07.005","article-title":"Evaluation of a continuous regimen of levonorgestrel\/ethinyl estradiol: phase 3 study results","volume":"74","author":"Archer","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.bpobgyn.2008.11.003_bib31","author":"National Institute for Health and Clinical Excellence"},{"key":"10.1016\/j.bpobgyn.2008.11.003_bib32","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0010-7824(02)00522-X","article-title":"The effect of levonorgestrel-releasing intrauterine device in the treatment of myoma-related menorrhagia","volume":"67","author":"Mercorio","year":"2003","journal-title":"Contraception"},{"key":"10.1016\/j.bpobgyn.2008.11.003_bib33","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/S0015-0282(03)00175-4","article-title":"Use of a levonorgestrel-releasing intrauterine system to treat bleeding related to uterine leiomyomas","volume":"79","author":"Grigorevia","year":"2003","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2008.11.003_bib34","first-page":"55","article-title":"Successful treatment of fibroids using an intrauterine progesterone device","volume":"46","author":"Singer","year":"1994","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.bpobgyn.2008.11.003_bib35","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0010-7824(99)00061-X","article-title":"Effect of the levonorgestrel-releasing intrauterine system on uterine myomas in a renal transplant patient","volume":"60","author":"Fong","year":"1999","journal-title":"Contraception"},{"key":"10.1016\/j.bpobgyn.2008.11.003_bib36","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.contraception.2006.11.004","article-title":"Uterine volume and menstrual patterns in users of the levonorgestrel releasing intrauterine system with idiopathic menorrhagia or menorrhagia due to leiomyomas","volume":"75","author":"Magalhaes","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.bpobgyn.2008.11.003_bib37","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S0039-128X(00)00171-9","article-title":"Effects of progesterone on uterine leiomyoma growth and apoptosis","volume":"65","author":"Maruo","year":"2000","journal-title":"Steroids"},{"key":"10.1016\/j.bpobgyn.2008.11.003_bib38","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1136\/bmj.293.6553.1027-b","article-title":"Risk factors for uterine fibroids: reduced risk associated with oral contraceptives","volume":"293","author":"Ross","year":"1986","journal-title":"BMJ"},{"key":"10.1016\/j.bpobgyn.2008.11.003_bib39","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1080\/01443610400009543","article-title":"Medical management of uterine fibroids with medroxyprogesterone acetate (Depo Provera): a pilot study","volume":"24","author":"Venkatachalam","year":"2004","journal-title":"J Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2008.11.003_bib40","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/humrep\/deh004","article-title":"The evaluation of the effectiveness of an intrauterine-administered progestogen (levonorgestrel) in the symptomatic treatment of endometriosis and in the staging of the disease","volume":"19","author":"Lockhat","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2008.11.003_bib41","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005072.pub2","article-title":"Levonorgestrel-releasing intrauterine device (LNG-IUD) for symptomatic endometriosis following surgery","volume":"4","author":"Abbou-Setta","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"issue":"Suppl.","key":"10.1016\/j.bpobgyn.2008.11.003_bib42","doi-asserted-by":"crossref","first-page":"S134","DOI":"10.1016\/j.contraception.2006.12.008","article-title":"Use of the levonorgestrel-releasing intrauterine system in women with endometriosis, chronic pelvic pain and dysmenorrhea","volume":"75","author":"Bahamondes","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.bpobgyn.2008.11.003_bib43","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.fertnstert.2006.11.044","article-title":"The levonorgestrel-releasing intrauterine system and endometriosis staging","volume":"87","author":"Gomes","year":"2007","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2008.11.003_bib44","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1093\/humrep\/deh650","article-title":"The efficacy, side-effects and continuation rates in women with symptomatic endometriosis undergoing treatment with an intra-uterine administered progestogen (levonorgestrel): a 3 year follow-up","volume":"20","author":"Lockhat","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2008.11.003_bib45","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001019.pub2","article-title":"Modern combined oral contraceptives for pain associated with endometriosis","volume":"3","author":"Davis","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.bpobgyn.2008.11.003_bib46","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/S0015-0282(03)00794-5","article-title":"Continuous use of an oral contraceptive for endometriosis-associated recurrent dysmenorrhea that does not respond to a cyclic pill regimen","volume":"80","author":"Vercellini","year":"2003","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2008.11.003_bib47","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S0002-9378(96)70152-7","article-title":"Depot medroxyprogesterone acetate versus an oral contraceptive combined with very-low-dose danazol for long-term treatment of pelvic pain associated with endometriosis","volume":"175","author":"Vercellini","year":"1996","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2008.11.003_bib48","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.contraception.2004.06.011","article-title":"Contraceptive efficacy and safety of DMPA-SC","volume":"70","author":"Jain","year":"2004","journal-title":"Contraception"},{"key":"10.1016\/j.bpobgyn.2008.11.003_bib49","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1093\/humrep\/dei290","article-title":"Subcutaneous depot medroxyprogesterone acetate versus leuprolide acetate in the treatment of endometriosis-associated pain","volume":"21","author":"Crosignani","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2008.11.003_bib50","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.fertnstert.2005.07.1315","article-title":"Subcutaneous injection of depot medroxyprogesterone acetate compared with leuprolide acetate in the treatment of endometriosis-associated pain","volume":"85","author":"Schlaff","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2008.11.003_bib51","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ejogrb.2006.08.002","article-title":"Use of a progestogen only preparation containing desogestrel in the treatment of recurrent pelvic pain after conservative surgery for endometriosis","volume":"135","author":"Razzi","year":"2007","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.bpobgyn.2008.11.003_bib52","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1783\/0000000052972799","article-title":"Treatment of pelvic endometriosis with etonogestrel subdermal implant (Implanon)","volume":"31","author":"Yisa","year":"2005","journal-title":"J Fam Plann Reprod Healthcare"},{"key":"10.1016\/j.bpobgyn.2008.11.003_bib53","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000069.pub2","article-title":"Ovulation suppression for endometriosis","volume":"18","author":"Hughes","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.bpobgyn.2008.11.003_bib54","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004425.pub3","article-title":"Combined oral contraceptive pills for treatment of acne","volume":"24","author":"Arowojolu","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.bpobgyn.2008.11.003_bib55","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1080\/09637480601137066","article-title":"Comparison of two oral contraceptives containing either drospirenone or cyproterone acetate in the treatment of hirsutism","volume":"23","author":"Batukan","year":"2007","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.bpobgyn.2008.11.003_bib56","doi-asserted-by":"crossref","first-page":"784","DOI":"10.3109\/00016349709024348","article-title":"Ovarian volume in gynecologically healthy women using contraception or using IUD","volume":"76","author":"Christensen","year":"1997","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.bpobgyn.2008.11.003_bib57","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","author":"Rotterdam\/ESHRE-ASHRM Sponsored PCOS Consensus Workshop Group","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2008.11.003_bib58","series-title":"Management of premenstrual syndrome. Green-top guideline no. 48","author":"Royal College of Obstetricians and Gynaecologists","year":"2007"},{"key":"10.1016\/j.bpobgyn.2008.11.003_bib59","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0022-3999(92)90090-O","article-title":"A prospective treatment study of pre-menstrual symptoms using a triphasic oral contraceptive","volume":"36","author":"Graham","year":"1992","journal-title":"J\u00a0Psychosom Res"},{"key":"10.1016\/j.bpobgyn.2008.11.003_bib60","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006586.pub2","article-title":"Oral contraceptives containing drospirenone for premenstrual syndrome","volume":"23","author":"Lopez","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.bpobgyn.2008.11.003_bib61","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.maturitas.2006.11.010","article-title":"Endometrial safety after 5 years of continuous combined transdermal estrogen and intrauterine levonorgestrel delivery for postmenopausal hormone substitution","volume":"57","author":"Wildemeersch","year":"2007","journal-title":"Maturitas"},{"key":"10.1016\/j.bpobgyn.2008.11.003_bib62","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1471-0528.2005.00541.x","article-title":"Current evidence about the effect of hormone replacement therapy on the incidence of major conditions in postmenopausal women","volume":"112","author":"Beral","year":"2005","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.bpobgyn.2008.11.003_bib63","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0010-7824(00)00086-X","article-title":"Low-dose oral contraceptives and bone mineral density: an evidence-based analysis","volume":"61","author":"Kuohung","year":"2000","journal-title":"Contraception"},{"key":"10.1016\/j.bpobgyn.2008.11.003_bib64","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1471-0528.1984.tb05899.x","article-title":"The recovery of pre-ovulatory oocytes using a fixed schedule of ovulation induction and follicle aspiration","volume":"91","author":"Templeton","year":"1984","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.bpobgyn.2008.11.003_bib65","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/S0015-0282(98)00333-1","article-title":"Effects of pretreatment with an oral contraceptive on the time required to achieve pituitary suppression with gonadotropin-releasing hormone analogues and on subsequent implantation and pregnancy rates","volume":"70","author":"Biljan","year":"1998","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2008.11.003_bib66","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1023\/A:1009462004650","article-title":"Does pretreatment with progestogen or oral contraceptive pills in low responders followed by the GnRHa flare protocol improve the outcome of IVF-ET?","volume":"17","author":"al-Mizyen","year":"2000","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.bpobgyn.2008.11.003_bib67","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.fertnstert.2007.07.1354","article-title":"Oral contraceptive pill pretreatment in ovarian stimulation with GnRH antagonists for IVF: a systematic review and meta-analysis","volume":"90","author":"Greisinger","year":"2008","journal-title":"Fertil Steril"}],"container-title":["Best Practice & Research Clinical Obstetrics & Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693408001533?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693408001533?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,22]],"date-time":"2018-12-22T14:50:20Z","timestamp":1545490220000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521693408001533"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":65,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["S1521693408001533"],"URL":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2008.11.003","relation":{},"ISSN":["1521-6934"],"issn-type":[{"value":"1521-6934","type":"print"}],"subject":[],"published":{"date-parts":[[2009,4]]}}}